Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio GlobeNewswire September 03, 2024 INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category.As life expectancy for pets increases, so does the need for effective treatment of debilitating diseases.

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Ads Links by Easy Branches
เล่นเกมออนไลน์ฟรีที่ games.easybranches.com

บริการโพสต์ thainews.easybranches.com/contribute
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Nepal Guide Treks and Expeditions Launches Initiative to Equip Beginner Climbers with Essential Mountaineering Skills on Island Peak

Give the Gift of Sustainable Packaging: The Packaging People Announce Christmas Packaging Solutions
Lenire Device Gets FDA Approved: Tinnitus Relief Here